IP Library Assignment 030034/0893
Patent Assignment
Reel/Frame 030034/0893

Assignment of Assignor's Interest

Recorded: 2013-03-18 Pages: 9
Assignor
Assignee
BAXTER HEALTHCARE SA
THURGAUERSTRASSE 130, GLATTPARK (OPFIKON), CH-8152, AUSTRIA
Covered Properties (21)
Interferon Inducing Genetically Engineered Attenuated Viruses
Patent: 6,468,544 →
Application: 09/332,287 →
Interferon Inducing Genetically Engineered Attenuated Viruses
Patent: 6,866,853 →
Application: 10/314,569 →
Publication: US 2003/0157131
Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
Patent: 7,510,862 →
Application: 10/490,920 →
Publication: US 2004/0241642
Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use
Application: 11/914,098 →
Publication: US 2009/0130129
Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
Patent: 8,008,460 →
Application: 12/261,374 →
Publication: US 2009/0180975
Method for influenza virus protection
Application: 12/309,135 →
Publication: US 2010/0158944
Medium Supplement for Virus Production
Patent: 8,288,145 →
Application: 12/444,248 →
Publication: US 2010/0003221
Attenuated Negative Strand Viruses with Altered Interferon Antagonist Activity for Use as Vaccines and Pharmaceuticals
Application: 12/480,410 →
Publication: US 2010/0158942
Antibodies Specific for the Melanoma-Associated Endogenous Retrovirus (Merv) Envelope Glycoprotein.
Patent: 8,541,553 →
Application: 12/601,780 →
Publication: US 2010/0136518
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Patent: 8,883,479 →
Application: 12/626,475 →
Publication: US 2010/0172934
Novel Method for Generation of Rna Virus
Patent: 8,778,357 →
Application: 12/630,655 →
Publication: US 2010/0184191
Replication Deficient Influenza Virus for the Expression of Heterologous Sequences
Application: 12/666,246 →
Publication: US 2010/0136052
Linear Expression Constructs for Production of Influenza Virus Particles
Application: 12/666,459 →
Publication: US 2010/0129399
Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use
Application: 12/768,076 →
Publication: US 2010/0285509
Modified Influenza Virus
Patent: 8,592,196 →
Application: 12/809,814 →
Publication: US 2010/0322970
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Patent: 8,815,252 →
Application: 13/129,806 →
Publication: US 2011/0223199
Novel Method for Generation of Rna Virus
Patent: 8,741,301 →
Application: 13/132,609 →
Publication: US 2011/0250587
High Growth Reassortant Influenza a Virus
Patent: 8,691,238 →
Application: 13/140,395 →
Publication: US 2011/0262481
Novel Influenza Virus
Patent: 9,771,564 →
Application: 13/386,355 →
Publication: US 2012/0164175
Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
Application: 13/451,256 →
Publication: US 2012/0237527
Novel Method for Generation of Rna Virus
Application: 13/701,164 →
Publication: US 2013/0183740
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 13, 2010
From: MEDICAL UNIVERSITY OF VIENNA
To: AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG
Reel/Frame 023772/0482 →
Amendment of Charter Feb 3, 2010
From: MOUNT SINAI SCHOOL OF THE CITY UNIVERSITY OF NEW YORK
To: MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY
Reel/Frame 023894/0248 →
Assignment of Assignor's Interest Feb 3, 2010
From: PALESE, PETER; GARCIA-SASTRE, ADOLFO; MUSTER, THOMAS
To: MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK
Reel/Frame 023894/0241 →
Correction of a Typographical Error in Name of the Conveying Party in the Recordation Cover Sheet for the Amendment of Charter Recorded on February 3, 2010 at Reel 023894, Frame 0248. Copies of Corrected Cover Sheet Are Attached. Feb 4, 2010
From: MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK
To: MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY
Reel/Frame 023901/0123 →
Assignment of Assignor's Interest Mar 14, 2013
From: AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG
To: BAXTER HEALTHCARE SA
Reel/Frame 029996/0569 →
Change of Name Jun 7, 2013
From: MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY
To: MOUNT SINAI SCHOOL OF MEDICINE
Reel/Frame 030575/0558 →
Change of Name Jul 17, 2013
From: MOUNT SINAI SCHOOL OF MEDICINE
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 030821/0582 →
Assignment of Assignor's Interest Oct 10, 2013
From: BAXTER HEALTHCARE S.A.
To: VIVALDI BIOSCIENCES INC.
Reel/Frame 031381/0973 →
Confirmatory License Sep 11, 2014
From: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033720/0155 →
Assignment of Assignor's Interest Dec 1, 2014
From: VIVALDI BIOSCIENCES INC.
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 034283/0815 →
Assignment of Assignor's Interest Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036368/0001 →
Assignment of Assignor's Interest Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0070 →
Assignment of Assignor's Interest Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0729 →
Assignment of Assignor's Interest Nov 24, 2015
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 037155/0732 →
Corrective Assignment to Correct the Correspondence Data Previously Recorded on Reel 037155 Frame 0732. Assignor(S) Hereby Confirms the Assignment. May 2, 2016
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038592/0044 →
Confirmatory License Jul 6, 2017
From: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
To: NIH-DEITR
Reel/Frame 042925/0200 →
Change of Name Mar 13, 2018
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 045581/0970 →
Security Interest May 1, 2018
From: OLOGY BIOSERVICES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046050/0305 →
Change of Name Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 048117/0275 →
Change of Name Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 049518/0666 →
Release of Security Interest Aug 20, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: OLOGY BIOSERVICES, INC.; NANO ADM, LLC
Reel/Frame 053561/0070 →
Assignment of Assignor's Interest Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0177 →
Change of Name Sep 8, 2022
From: OLOGY BIOSERVICES, INC.
To: RESILIENCE GOVERNMENT SERVICES, INC.
Reel/Frame 061399/0903 →
Change of Name Nov 20, 2025
From: RESILIENCE GOVERNMENT SERVICES, INC,
To: ALACHUA GOVERNMENT SERVICES, INC.
Reel/Frame 073279/0021 →